The Influence of Using Vascularized Vaginal Flap on the Efficacy of Mesh-augmented Sacrospinous Hysteropexy
The Influence of Augmentation of the Anterior Vaginal Wall With a Vascularized Flap on the Effectiveness of Mesh-augmented Sacrospinous Hysteropexy and Anterior Subfascial Colporrhaphy During Reconstruction of the Pelvic Floor for POP
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a prospective randomized controlled trial designed to compare the effectiveness and safety of two methods of pelvic floor reconstruction in patients with pelvic organ prolapse (POP): sacrospinous hysteropexy (SSHP) with synthetic mesh, vascularized anterior vaginal wall flap, anterior colporrhaphy, and sacrospinous hysteropexy with synthetic mesh. , anterior colporrhaphy, as well as the impact of surgery on quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJuly 10, 2024
July 1, 2024
5 months
March 25, 2024
July 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Objective cure rate
The patient is considered cured if there is no prolapse beyond the hymen and the cervix is above -1 cm according to POP-Q (0-1 stage)
12 months (1 year)
Secondary Outcomes (4)
Satisfaction with the surgery
Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks
The impact of treatment on sexual function
Measured postoperatively at intervals of 6, 12 months postoperatively, Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks
The impact of treatment on the quality of life
Measured postoperatively at intervals of 6, 12 months postoperatively, Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks
Observed complications
Measured postoperatively at intervals of 6, 12 months postoperatively, Measured postoperatively at intervals of 6, 12 months postoperatively, up to 100 weeks
Study Arms (2)
Sacrospinous hysteropexy with the synthetic mesh, vaginal flap and anterior colporrhaphy
ACTIVE COMPARATORSacrospinous hysteropexy with the synthetic mesh and anterior colporrhaphy
ACTIVE COMPARATORInterventions
Sacrospinous hysteropexy with the synthetic mesh, vaginal flap and anterior colporrhaphy
Sacrospinous hysteropexy with the synthetic mesh and anterior colporrhaphy
Eligibility Criteria
You may qualify if:
- The subject is a woman with anterior and apical compartment pelvic organ prolapse
- The age of a subject is 45-80 years
- Leading point of prolapse is at the level of the hymen or distal to the hymen (Ba, C\>=1 according to POP-Q classification)
- The subject gave written consent to participate in the study
- The subject is able to evaluate the risks of the treatment and make an independent decision on participation in the study
- The subject is able to fill up validated questionnaires and come to the control visit after the surgery
You may not qualify if:
- The subject has an active urinary tract infection or skin infection in the region of surgery or acute infectious disease
- The subject had prior hysterectomy
- The subject has previously diagnosed or currently active cancer
- The subject has chronic pelvic pain
- The subject has cervical elongation
- The subject has gynecological diseases (recurrent uterine bleeding, endometrial hyperplasia, the presence of atypical cells in cervical smears, adenomyosis, multiple uterine myoma)
- The subject is planning pregnancy
- The subject is unable to visit postoperative check-ups
- Refusal from participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint-Petersburg State University Hospital
Saint Petersburg, 190103, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dmitry Shkarupa, MD, PhD
Saint Petersburg State University, Russia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD; Director, St. Petersburg State University Hospital
Study Record Dates
First Submitted
March 25, 2024
First Posted
July 10, 2024
Study Start
May 1, 2024
Primary Completion
October 1, 2024
Study Completion
October 1, 2025
Last Updated
July 10, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share